A Phase 2 double-blind randomized placebo-controlled crossover study evaluating the effect of RVT-101 on gait and balance in subjects with Alzheimer's Disease Dementia with Lewy Bodies or Parkinson's Disease Dementia

J
Jared Brosch, MD

Primary Investigator

J
Jessica MacLean

Primary Investigator

Overview

The purpose of this study is to investigate whether RVT-101 can improve gait and balance in subjects with Alzheimer?s disease, dementia with Lewy bodies, or Parkinson?s disease dementia who suffer from problems related to balance, walking, and falls.

Description

The purpose of this study is to investigate whether RVT-101 can improve gait and balance in subjects with Alzheimer's disease, dementia with Lewy bodies, or Parkinson's disease dementia who suffer from problems related to balance, walking and falls.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Alzheimer's disease,dementia with Lewy bodies
  • Age: Between 50 Years - 89 Years
  • Gender: All
Updated on 20 Nov 2022. Study ID: 1611337897

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center